Contact dermatitis is an inflammation of the skin that can be acute or chronic that manifests as eczematous dermatitis due to exposure to substances in the environment.
Allergic contact dermatitis is an immunologic cell-mediated skin reaction to exposure to antigenic substances.
The lesions initially appear on the cutaneous site of principal exposure then may spread to other more distant sites due to contact or autosensitization. Lesions are typically asymmetrical and unilateral.
Specific signs and symptoms will depend on the duration, location, degree of sensitivity and concentration of allergens. The patch test shows reaction to allergen.
Irritant contact dermatitis is a non-immunologic skin reaction to skin irritants.
It is often localized to areas of thin skin eg eyelids, intertriginous areas.
Belsito DV. The diagnostic evaluation, treatment, and prevention of allergic contact dermatitis in the new millennium. J Allergy Clin Immunol. 2000 Mar;105(3):409-420. PMID: 10719287
Blauvelt A, Huang ST, Udey MC. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S560-S570. PMID: 12592302
Bruckner AL, Weston WL. Allergic contact dermatitis in children: a practical approach to management. Skin Ther Lett. 2002 Oct;7(8):3-5. PMID: 12548328
Drake LA, Dorner W, Goltz RW, et al. Guidelines of care for contact dermatitis. J Am Acad Dermatol. 1995 Jan;32(1):109-113. http://www.ncbi.nlm.nih.gov/pubmed/?term=7822498. PMID: 7822498
Fyhrquist-Vanni N, Alenius H, Lauerma A. Contact dermatitis. Dermatol Clin. 2007 Oct;25(4):613-623. http://www.ncbi.nlm.nih.gov/pubmed/?term=17903620. PMID: 17903620
Leung D, Schatz M. Consultation and referral guidelines citing the evidence: how the allergist-immunologist can help. J Allergy Clin Immunol. 2006 Feb;117(Suppl 2 Suppl Consultation):S495-S523. http://www.jacionline.org/article/S0091-6749(05)02579-0/pdf. PMID: 16553071
Kennedy MS. Comprehensive care in the allergy/asthma office: evaluation of chronic eczema and urticaria and angioedema. Immunol Allergy Clin North Am. 1999;19(1):19-33
Heymann WR. Hand dermatitis. J Am Acad Dermatol. 2006 Jun;54:1078-1080. http://www.jaad.org/article/S0190-9622(06)00324-0/pdf. PMID: 16713475
Mark BJ, Slavin RG. Allergic contact dermatitis. Med Clin North Am. 2006 Jan;90(1):169-185. http://www.ncbi.nlm.nih.gov/pubmed/?term=Mark+BJ%2C+Slavin+RG%09Allergic+contact+dermatitis. PMID: 16310529
Ong PY, Boguniewicz M. Atopic dermatitis and contact dermatitis in the emergency department. Clin Pediatr Emerg Med. 2007;8(2):81-86. http://www.clinpedemergencymed.com/article/S1522-8401(07)00023-7/pdf.
Tan CH, Rasool S, Johnston GA. Contact dermatitis: Allergic and irritant. Clin Dermatol. 2014 Jan;32(1):116-124. www.cidjournal.com/article/S0738-081X(13)00100-4/pdf. PMID: 24314385
Fonacier L, Bernstein DI, Pacheco K, et al; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology; Joint Council of Allergy, Asthma & Immunology. Contact dermatitis: a practice parameter-update 2015. J Allergy Clin Immunol Pract. 2015 May;3(Suppl 3):S1-S39. https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Contact-dermatitis-2015.pdf. Accessed 13 Apr 2016. PMID: 25965350
Brod BA. Management of allergic contact dermatitis. UpToDate. www.uptodate.com. Feb 2018.
Goldner R. Irritant contact dermatitis in adults. UpToDate. www.uptodate.com. Aug 2018.
Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-329. doi: 10.1111/bjd.15239. PMID: 28244094
Schalock PC, Dunnick CA, Nedorost S, et al. American Contact Dermatitis Society core allergen series. Dermatitis. 2013 Jan;24(1):7-9. doi: 10.1097/DER.0b013e318281d87b. PMID: 23340393
While early-phase clinical trials may demonstrate substantial levels of overall response rates in patients with relapsed/refractory multiple myeloma (RRMM), high heterogeneity of evidence prevents the accurate assessment of clinical benefit before patient participation, reports a recent meta-analysis.
The COVID-19 vaccine AZD1222 by AstraZeneca and the University of Oxford was 79 percent effective overall in preventing symptomatic infections – higher than observed in previous clinical trials of the vaccine – at the interim analysis of a US phase III trial.
Migraine and headache are common ailments of people living in the modern era. Dr Jon Marshall of The Singapore Headache and Migraine Clinic shares his insights with Pearl Toh on how to manage migraine and headache using non-pharmaceutical strategies, with a focus on the manual medicine approach.